In the BioHarmony Drug Report Database

"Preview" Icon

Indomethacin

Indocin, Indocin Sr, Indomethacin, Tivorbex (indomethacin) is a small molecule pharmaceutical. Indomethacin was first approved as Indocin on 1982-01-01. It is used to treat ankylosing spondylitis, bursitis, gouty arthritis, inflammation, and osteoarthritis amongst others in the USA. It is known to target prostaglandin D2 receptor 2, peroxisome proliferator-activated receptor gamma, proton-coupled folate transporter, prostaglandin G/H synthase 2, prostaglandin G/H synthase 1, and aldo-keto reductase family 1 member C3. Indocin’s patent is valid until 2030-04-23 (FDA).

 

Trade Name

 

Indocin, Indocin Sr, Indomethacin, Tivorbex
 

Common Name

 

indomethacin
 

ChEMBL ID

 

CHEMBL6
 

Indication

 

ankylosing spondylitis, bursitis, gouty arthritis, inflammation, osteoarthritis, pain, patent ductus arteriosus, rheumatoid arthritis, tendinopathy
 

Drug Class

 

Image (chem structure or protein)

Indomethacin structure rendering